FDA expands indication for asthma rescue inhaler to younger patients – Healio

FDA expands indication for asthma rescue inhaler to younger patients
Healio
Teva Pharmaceuticals announced today that the FDA has expanded the indication for its ProAir, RespiClick inhalation powder to include patients with asthma aged 4 to 11 years, according to a press release.
Teva Pharma (TEVA) Receives FDA Approval for ProAir RespiClick for Pediatric Asthma Patients Ages 4 to 11StreetInsider.com
FDA Expands Breath-Actuated Inhaler Use to Kids as Young as 4Medscape

all 5 news articles »

View full post on asthma – Google News

FDA expands indication of BI inhaler to include maintenance treatment of asthma – FierceDrugDelivery

FDA expands indication of BI inhaler to include maintenance treatment of asthma
FierceDrugDelivery
The only inhaler that administers a slow-moving mist to help respiratory patients inhale the medication is now FDA-approved for the long-term maintenance treatment of asthma, in addition to its previous indication to treat COPD. The expanded indication
FDA Approves New Indication for Boehringer's Spiriva RespimatDrug Discovery & Development
Landmark year for Boehringer Ingelheim's respiratory portfolio – new data for The FINANCIAL
ERS 2015: Landmark year for Boehringer Ingelheim's respiratory portfolio – new Business Wire (press release)

all 15 news articles »

View full post on asthma – Google News

Mobile Asthma Center Expands Services in East Bay – Patch.com


Patch.com

Mobile Asthma Center Expands Services in East Bay
Patch.com
The “Breathmobile” will now be bringing its mobile asthma services into three new locations whose populations suffer heavily from asthma. The $100,000 grant was approved by the Bay Area Air Quality Management District Sept. 2 during the district's
Breathmobile coming to San Pablo thanks to grantRichmond Standard

all 2 news articles »

View full post on asthma – Google News

Propeller Health expands Air Louisville public health asthma pilot – MobiHealthNews


MobiHealthNews

Propeller Health expands Air Louisville public health asthma pilot
MobiHealthNews
“They did things like put up air quality meters in the city and then also, back then, worked with Propeller to put 300 residents on our sensor to see — really within the city — where asthma was happening. That was pretty successful. We were able to

View full post on asthma – Google News

GSK Expands Portfolio of Asthma/COPD Medicines in U.S. – Drug Discovery & Development


Monthly Prescribing Reference

GSK Expands Portfolio of Asthma/COPD Medicines in U.S.
Drug Discovery & Development
GlaxoSmithKline plc announced the simultaneous availability of two of its recently approved products for the treatment of asthma and COPD to retail pharmacies in the US. Over the past 15 months, GSK has launched four inhaled respiratory therapies in
GSK Expands Its Portfolio Of Medicines In US To Treat Asthma And COPDRTT News
New Inhalers for Asthma, COPD LaunchedMonthly Prescribing Reference
GSK expands its portfolio of medicines in the US for patients with asthma and SYS-CON Media (press release)

all 5 news articles »

View full post on asthma – Google News

GSK Expands Its Portfolio Of Medicines In US To Treat Asthma And COPD – RTT News


Monthly Prescribing Reference

GSK Expands Its Portfolio Of Medicines In US To Treat Asthma And COPD
RTT News
Arnuity Ellipta (fluticasone furoate inhalation powder) is a once-daily inhaled corticosteroid (ICS) medicine for the maintenance treatment of asthma. It is the first product in the Ellipta inhaler for the treatment of asthma to be introduced in the US
New Inhalers for Asthma, COPD LaunchedMonthly Prescribing Reference
GSK Expands Portfolio of Asthma/COPD Medicines in U.S.Drug Discovery & Development
GSK expands its portfolio of medicines in the US for patients with asthma and SYS-CON Media (press release)

all 6 news articles »

View full post on asthma – Google News

GSK Expands Its Asthma and COPD Portfolio in the US – Pharmaceutical Processing


SYS-CON Media

GSK Expands Its Asthma and COPD Portfolio in the US
Pharmaceutical Processing
GlaxoSmithKline has announced the simultaneous availability of two of its recently approved products for the treatment of asthma and COPD to retail pharmacies in the US. Over the past 15 months, GSK has launched four inhaled respiratory therapies in
GSK Expands Its Portfolio Of Medicines In US To Treat Asthma And COPDRTT News
GSK expands its portfolio of medicines in the US for patients with asthma and MarketWatch

all 4 news articles »

View full post on asthma – Google News

Asthmapolis Expands its Asthma Management Study – news Stories

Asthmapolis Expands its Asthma Management Study
news Stories
Asthmapolis announced that it will expand its free asthma management study at Woodland Healthcare in Woodland, Calif, to also include patients from Mercy Medical Group, a part of the Dignity Health system, located in Sacramento, Calif. According to
Asthmapolis Expands Dignity Health Study to Include Mercy Medical Group MarketWatch (press release)

all 7 news articles »

View full post on asthma – Google News